Regulatory Capture — Orange Pill Wiki
CONCEPT

Regulatory Capture

The structural dynamic by which regulated industries shape the regulations that govern them — the primary mechanism through which installation-phase incumbents delay or dilute deployment-phase institutional construction.

Regulatory capture is the phenomenon in which regulatory agencies come to serve the interests of the industries they are meant to regulate rather than the public interest. The pattern is consistent across regulatory domains and historical periods: the parties most affected by regulation invest the most in shaping it, and the result is regulation that serves the regulated as much as the public. The mechanisms include direct lobbying, revolving-door employment between industry and regulatory agencies, selective provision of technical expertise, campaign contributions, and the gradual socialization of regulators into the worldview of the industries they oversee. For AI regulation, capture operates through all these mechanisms, amplified by the concentration of technical expertise in a small number of companies.

In the AI Story

Hedcut illustration for Regulatory Capture
Regulatory Capture

Every previous turning point featured a contest in which regulatory capture was a central dynamic. The canal companies captured parliamentary oversight of waterway regulation. The railway companies captured rate-setting boards. The broadcast media captured the FCC. The platform companies of the ICT age captured regulatory processes in both the US and Europe, producing decades of permissive treatment that contributed to the incomplete deployment phase.

AI capture operates through familiar mechanisms with some novel features. The lobbying expenditures of technology companies in the United States and Europe have increased dramatically since 2023. The revolving door between regulatory agencies and AI companies continues to spin. The concentration of technical expertise — most people who deeply understand AI systems work for AI companies — means that regulators depend on industry sources for the information they need to regulate, creating structural information asymmetry that favors the regulated.

The capture risk is particularly acute for supply-side regulation because it directly affects the competitive dynamics of the AI industry. Demand-side regulation — investment in citizen capability, education, transition support — attracts less intense lobbying because it does not directly affect industry profitability. This asymmetry is one of the reasons demand-side regulation is both more resistant to capture and more consequential for the deployment phase.

Resisting capture requires institutional mechanisms that have historically proven effective: public funding of independent technical expertise, robust whistleblower protections, transparency requirements for regulator-industry interactions, and — most fundamentally — strong political coalitions that can counterbalance incumbent interests during the turning point's window of opportunity.

Origin

The concept of regulatory capture was developed in the public choice literature by George Stigler and others in the late twentieth century. Perez's framework integrates it into the broader pattern of installation-phase incumbents shaping turning-point outcomes.

Key Ideas

Structural dynamic. Parties most affected by regulation invest most in shaping it.

Multiple mechanisms. Lobbying, revolving door, technical expertise asymmetry, campaign contributions.

Historical pattern. Every previous turning point featured capture contests.

AI-specific features. Technical expertise concentration amplifies information asymmetry.

Countermeasures. Independent expertise, transparency, whistleblower protections, strong reform coalitions.

Appears in the Orange Pill Cycle

Further reading

  1. George Stigler, "The Theory of Economic Regulation" (1971)
  2. Daniel Carpenter and David Moss, Preventing Regulatory Capture (2014)
  3. Lawrence Lessig, Republic, Lost (2011)
Part of The Orange Pill Wiki · A reference companion to the Orange Pill Cycle.
0%
CONCEPT